W.H. Yang

847 total citations
19 papers, 641 citations indexed

About

W.H. Yang is a scholar working on Genetics, Immunology and Allergy and Rheumatology. According to data from OpenAlex, W.H. Yang has authored 19 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Immunology and Allergy and 6 papers in Rheumatology. Recurrent topics in W.H. Yang's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers), Urticaria and Related Conditions (6 papers) and Allergic Rhinitis and Sensitization (5 papers). W.H. Yang is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers), Urticaria and Related Conditions (6 papers) and Allergic Rhinitis and Sensitization (5 papers). W.H. Yang collaborates with scholars based in United States, Canada and Germany. W.H. Yang's co-authors include Niels Johansen, Michael Pedersen, S. Rak, Stephen R. Durham, C. Kirk Osterland, G. Dorval, Jacob Karsh, Kraig W. Jacobson, David Hurewitz and Norbert Gilmore and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Clinical & Experimental Immunology.

In The Last Decade

W.H. Yang

17 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.H. Yang United States 8 412 371 207 190 79 19 641
Jacinto Lara France 8 136 0.3× 226 0.6× 35 0.2× 20 0.1× 6 0.1× 26 335
Adriane Peveling‐Oberhag Germany 7 49 0.1× 43 0.1× 83 0.4× 166 0.9× 5 0.1× 15 372
Ragıp Ertaş Türkiye 11 28 0.1× 49 0.1× 127 0.6× 146 0.8× 6 0.1× 40 414
M. L. Hamelink Netherlands 9 112 0.3× 215 0.6× 14 0.1× 11 0.1× 3 0.0× 16 341
Atsuko Fukuyasu Japan 10 103 0.3× 77 0.2× 190 0.9× 44 0.2× 32 309
Vivian Laquer United States 12 154 0.4× 66 0.2× 268 1.3× 5 0.0× 1 0.0× 37 392
Saki Fukaya Japan 9 94 0.2× 69 0.2× 160 0.8× 44 0.2× 31 277
Javier I. Muñoz‐González Spain 9 118 0.3× 87 0.2× 4 0.0× 53 0.3× 21 388
Sora Takeuchi Japan 12 21 0.1× 18 0.0× 35 0.2× 18 0.1× 3 0.0× 30 270
Nina Avshovich Israel 5 30 0.1× 20 0.1× 56 0.3× 157 0.8× 8 342

Countries citing papers authored by W.H. Yang

Since Specialization
Citations

This map shows the geographic impact of W.H. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.H. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.H. Yang more than expected).

Fields of papers citing papers by W.H. Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.H. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.H. Yang. The network helps show where W.H. Yang may publish in the future.

Co-authorship network of co-authors of W.H. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of W.H. Yang. A scholar is included among the top collaborators of W.H. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.H. Yang. W.H. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Xiao, Yu, et al.. (2024). A comprehensive analysis on the safety of two biologics dupilumab and omalizumab. Frontiers in Medicine. 11. 1435370–1435370.
2.
Maurer, Marcus, William R. Lumry, H. Henry Li, et al.. (2023). Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study. The Journal of Allergy and Clinical Immunology In Practice. 12(1). 201–211.e6. 15 indexed citations
3.
Yang, W.H., et al.. (2020). M559 SUCCESSFUL TREATMENT AND STEROID SPARING USING OMALIZUMAB FOR BULLOUS PEMPHIGOID REQUIRING PREDNISONE AND INTRAVENOUS IMMUNOGLOBULIN. Annals of Allergy Asthma & Immunology. 125(5). S115–S116. 2 indexed citations
4.
Yang, W.H., et al.. (2020). M557 SUCCESSFUL TREATMENT AND COMPLETE STEROID SPARING USING OMALIZUMAB IN BULLOUS PEMPHIGOID MASQUERADING AS REFRACTORY URTICARIA. Annals of Allergy Asthma & Immunology. 125(5). S115–S115. 3 indexed citations
5.
Malbrán, Alejandro, Marc A. Riedl, Bruce Ritchie, et al.. (2014). Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial. Clinical & Experimental Immunology. 177(2). 544–553. 32 indexed citations
6.
Craig, Timothy, Againdra K. Bewtra, Sami L. Bahna, et al.. (2011). C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study. Allergy. 66(12). 1604–1611. 104 indexed citations
7.
Goodman, Susan M., Robyn J. Levy, Againdra K. Bewtra, et al.. (2010). C1 Esterase Inhibitor (C1-INH) Concentrate in the Treatment of Acute Attacks in Hereditary Angioedema: Interim Results of the Treatment of 975 Attacks in an Ongoing, Prospective, Open-Label Study in North America (I.M.P.A.C.T.2). Journal of Allergy and Clinical Immunology. 125(2). AB166–AB166. 2 indexed citations
8.
Wasserman, Richard L., Againdra K. Bewtra, James N. Moy, et al.. (2009). C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2). Journal of Allergy and Clinical Immunology. 123(2). S99–S99. 3 indexed citations
9.
Nathan, R.A., William E. Berger, W.H. Yang, et al.. (2007). Once Daily Fluticasone Furoate∗ Nasal Spray (FFNS), a Novel Enhanced Affinity Steroid, Provides 24-hour Relief for the Nasal Symptoms of Perennial Allergic Rhinitis (PAR). Journal of Allergy and Clinical Immunology. 119(1). S65–S65. 4 indexed citations
10.
Durham, Stephen R., W.H. Yang, Michael Pedersen, Niels Johansen, & S. Rak. (2006). Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis. Journal of Allergy and Clinical Immunology. 117(4). 802–809. 375 indexed citations
11.
Connors, Lori, W.H. Yang, & Gina Lacuesta. (2006). Case Reports of Seed Anaphylaxis: Mustard, Flax and Sunflower Seed. Journal of Allergy and Clinical Immunology. 117(2). S52–S52. 1 indexed citations
12.
Philip, George, et al.. (2005). Efficacy of montelukast for treating perennial allergic rhinitis. Journal of Allergy and Clinical Immunology. 115(2). S267–S267.
13.
Xue, Charlie Changli, et al.. (2003). Effect of adding a Chinese herbal preparation to acupuncture for seasonal allergic rhinitis: randomised double-blind controlled trial.. PubMed. 9(6). 427–34. 14 indexed citations
14.
Yang, W.H., et al.. (1998). C1-Esterase Inhibitor Transfusions in Patients with Hereditary Angioedema. Annals of Allergy Asthma & Immunology. 80(6). 457–461. 30 indexed citations
15.
Yang, W.H., et al.. (1990). Potentially fatal hereditary angioedema: a review and case report.. PubMed. 56(12). 1096–9. 7 indexed citations
16.
Yang, W.H., et al.. (1987). Specific IgE antibody responses to ragweed allergens Ra5S and Ra5G associated with distinct HLA-DR β genes. Molecular Immunology. 24(11). 1207–1210. 15 indexed citations
17.
Yang, W.H., et al.. (1985). 373 Positive Prausnitz-Küstner reaction in metabisulfite sensitive subjects. Journal of Allergy and Clinical Immunology. 75(1). 198–198. 1 indexed citations
18.
Yang, W.H., G. Dorval, C. Kirk Osterland, & Norbert Gilmore. (1979). Circulating immune complexes during immunotherapy. Journal of Allergy and Clinical Immunology. 63(5). 300–307. 32 indexed citations
19.
Dorval, G., W.H. Yang, Raja B. Khan, C. Kirk Osterland, & J.H. Toogood. (1978). 104. Circulating immune complexes in hypersensitivity pneumonitis. Journal of Allergy and Clinical Immunology. 61(3). 159–159. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacinto Lara Breakdown of academic impact, for papers by Adriane Peveling‐Oberhag Breakdown of academic impact, for papers by Ragıp Ertaş Breakdown of academic impact, for papers by M. L. Hamelink Breakdown of academic impact, for papers by Atsuko Fukuyasu Breakdown of academic impact, for papers by Vivian Laquer Breakdown of academic impact, for papers by Saki Fukaya Breakdown of academic impact, for papers by Javier I. Muñoz‐González Breakdown of academic impact, for papers by Sora Takeuchi Breakdown of academic impact, for papers by Nina Avshovich
Rankless by CCL
2026